Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
DBV Technologies S.A. (NASDAQ:DBVT – Get Free Report) Director Timothy E. Morris acquired 12,000 shares of DBV Technologies stock in a transaction dated Friday, August 25th. The shares were bought at an average cost of $1.52 per share, for a total transaction of $18,240.00. Following the completion of the purchase, the director now directly owns […]
MELBOURNE, Australia, May 17, 2023 Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced. | May 17, 2023
MELBOURNE, Australia, May 08, 2023 Opthea Limited , a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced. | May 8, 2023
MELBOURNE, Australia, April 28, 2023 (GLOBE NEWSWIRE) Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today